Giovanni Tramonti
Edinburgh, SCT, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
The 21-gene recurrence score assay as a tool for predicting recurrence risk and guiding adjuvant treatment selection in early breast cancer.
Journal: Expert review of molecular diagnostics
Published: August 05, 2026
The 21-gene recurrence score assay as a tool for predicting recurrence risk and guiding adjuvant treatment selection in early breast cancer.
Journal: Expert review of molecular diagnostics
Published: August 05, 2026
The End of 'Pay-and-Hope': Managing Accelerated Approvals with Outcomes-Based Reimbursement in the Era of Routinely Collected Health Data.
Journal: PharmacoEconomics
Published: May 21, 2026
Association between neoadjuvant paclitaxel dose intensity and outcomes in early triple-negative and HER2-positive breast cancer: a real-world data analysis.
Journal: ESMO real world data and digital oncology
Published: February 06, 2026
Variation in hospital cost trajectories at the end of life by age, multimorbidity and cancer type.
Journal: International journal of population data science
Published: February 01, 2023
Defining Biochemical Cure After Low Dose Rate Prostate Brachytherapy: External Validation of 4-year Prostate-specific Antigen Nadir as a Predictor of 10- and 15-year Disease-free Survival.
Journal: Clinical oncology (Royal College of Radiologists (Great Britain))
Published: June 11, 2021
Probabilistic One-Way Sensitivity Analysis with Multiple Comparators: The Conditional Net Benefit Frontier.
Journal: PharmacoEconomics
Published: November 10, 2020
Showing 1-8 of 8
Last Updated: 09/26/2026